Resources

For the latest in nextgen biomed, sign up for our monthly newsletter to be among the first to receive exclusive insights, in-depth market analyses, and expert articles directly to your inbox

Antibody & Protein Engineering

AstraZeneca Suffers Sales Decline for COVID Med Evusheld

A 24 million loss has been reported for the preventative COVID-19 treatment.
Antibody & Protein Engineering

Market Battle for Rare Disease Treatment

Argenx and AstraZeneca are set to become market rivals in their general myasthenia gravis (gMG) treatments, analysts claim.
NextGen Therapeutics

Bispecific Antibodies for Solid Tumours

Laura von Schantz, Vice President of Discovery at Alligator Bioscience, leads a discussion on the current and future opportunities of bispecific antibodies for solid tumour treatment.

European Approval for Monkeypox Vaccine

The European Commission (EC) has approved Bavarian Nordic’s Imvanex vaccine which protects against monkeypox, and diseases caused by the vaccinia virus.

Discussion Group Announcement

Oxford Global’s next round of Biologics Discussion Groups announced.
Antibody & Protein Engineering

Widening the Therapeutic Window: Development of Antibody Drug Conjugates for Solid Tumours

Compared to non-solid tumours, solid tumours are more difficult to treat with conventional therapeutic methods. Antibody drug conjugates – biopharmaceutical drugs designed as a targeted therapy for treating cancer – represent a viable treatment alternative.
Antibody & Protein Engineering

Novartis Withdraws Tislelizumab Submission

Novartis scraps US submission of tislelizumab as a monotherapy for non-small cell lung cancer.

New Speakers Announced: Vaccines Europe Congress 2022

Exciting updates revealed about upcoming Vaccines Europe: In-Person congress happening 29-30 November 2022.
Antibody & Protein Engineering

Blood Test Predicts Presence of Beta-Amyloid in Brain

A study by the National Institute of Ageing found that a new blood test can accurately predict the presence of beta-amyloid plaques in the brain.

US Doubles its Supply of Monkeypox Vaccines

The US government has more than doubled its supply of Monkeypox vaccines amidst rising fears.
NextGen Therapeutics

AstraZeneca Buys T Cell Engager for $100 Million

Pharma giant makes a major investment in improving the standards of care in B cell malignancies.
Antibody & Protein Engineering

Recommended Approval for AbbVie’s Rinvoq Treatment

AbbVie announces official recommended approval of it Rinvoq treatment for adults with active non-radiographic axial spondyloarthritis.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery